OnKure Therapeutics (OKUR) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 3, 2026, with voting open until June 2, 2026, at 11:59 PM ET.

• Shareholders can access proxy materials online or request paper/email copies by May 20, 2026.

• Meeting will be held virtually, allowing remote participation and voting.

Voting matters and shareholder proposals

• Election of three Class II directors to serve until the 2029 annual meeting.

• Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Amendment and restatement of the 2024 Equity Incentive Plan to increase reserved shares by approximately 8% and remove the annual limit from the evergreen provision.

• Proxies authorized to vote on other business as may arise during the meeting.

Board of directors and corporate governance

• Nominees for Class II director positions: R. Michael Carruthers, Valerie M. Jansen, M.D., Ph.D., and Edward T. Mathers.